IMMUNIC, INC. — Proxy Solicitation & Information Statement 2015

Oct 7, 2015

DEFA14A 1 a420821_defa14a.htm DEFINITIVE ADDITIONAL MATERIALS

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the Securities

Exchange Act of 1934 (Amendment No. )

Filed by the Registrant x

Filed by a Party other than the Registrant ¨

Check the appropriate box:

¨ Preliminary Proxy Statement

¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

¨ Definitive Proxy Statement

x Definitive Additional Materials

¨ Soliciting Material Pursuant to §240.14a-12

VITAL THERAPIES, INC.

Field: Rule-Page

Field: /Rule-Page

(Name of Registrant as Specified In Its Charter)

Field: Rule-Page

Field: /Rule-Page

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

x No fee required.

¨ Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

(1) Title of each class of securities to which transaction applies:

Field: Rule-Page

Field: /Rule-Page

(2) Aggregate number of securities to which transaction applies:

Field: Rule-Page

Field: /Rule-Page

(3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

Field: Rule-Page

Field: /Rule-Page

(4) Proposed maximum aggregate value of transaction:

Field: Rule-Page

Field: /Rule-Page

(5) Total fee paid:

Field: Rule-Page

Field: /Rule-Page

¨ Fee paid previously with preliminary materials.

¨ Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

(1) Amount Previously Paid:

Field: Rule-Page

Field: /Rule-Page

(2) Form, Schedule or Registration Statement No.:

Field: Rule-Page

Field: /Rule-Page

(3) Filing Party:

Field: Rule-Page

Field: /Rule-Page

(4) Date Filed:

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

important notice of availability of Proxy materials for the Stockholder meeting of Vital Therapies, Inc. to Be held on November 17, 2015 at 8:00 a.m. the offices of Wilson Sonsini Goodrich & Rosati, Professional Corporation located at one market Plaza, Spear tower, 1 market Street, Suite 3300, San Francisco, California 94105 company number account number Control number this communication presents only an overview of the more complete proxy materials that are available to you on the internet. We encourage you to access and review all of the important information contained in the proxy materials before voting if you want to receive a paper or e-mail copy of the proxy materials you must request one. There is no charge to you for requesting a copy to facilitate timely delivery please make the request as instructed below before 11/6/15. Please visit http://www.astproxyportal.com/ast/18939, where the following materials are available for view: Notice of Annual Meeting of Stockholders Proxy Statement Form of Electronic Proxy Card Annual Report on Form 10-K to request material: telephone: 888-Proxy-na (888-776-9962) 718-921-8562 (for international callers) e-mail: info@amstock.com website: http://www.amstock.com/proxyservices/requestmaterials.asp to Vote: onLine: To access your online proxy card, please visit www.voteproxy.com and follow the on-screen instructions or scan the QR code with your smartphone. You may enter your voting instructions at www.voteproxy.com up until 11:59 PM Eastern Time the day before the cut-off or meeting date. In Person: You may vote your shares in person by attending the Annual Meeting. telephone: To vote by telephone, please visit www.voteproxy.com to view the materials and to obtain the toll free number to call. mail: You may request a card by following the instructions above. 1. To elect the following Class I Director Nominees Nominees: Terence E. Winters, Ph.D. Philip M. Croxford Randolph C. Steer, M.D., Ph.D. 2. To ratify the appointment of PricewaterhouseCoopers LLC as Vital Therapies’ independent registered public accounting firm for the fiscal year ending December 31, 2015. In their discretion, the proxies are authorized to vote upon such other business as may properly come before the annual meeting or any adjournments or postponements thereof. the board of directors recommends a Vote “For” all the nominees listed in Proposal 1 and “For” proposal 2. Directions to the 2015 Annual Meeting of Stockholders of Vital Therapies, Inc. are available in the proxy statement, which can be viewed at http://www.astproxyportal.com/ast/18939. Please note that you cannot use this notice to vote by mail.

Field: Page; Sequence: 2

Field: /Page